Congress Materials – American Society of Hematology (ASH 2024)

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

A Retrospective Database Analysis of Healthcare Resource Utilization in Patients With Warm Autoimmune Hemolytic Anemia in the United States

Louis Jackson, Shannon Ferrante, Jacqueline Pesa, Alicia K. Campbell, Zia Choudhry, Caroline Piatek

 

View poster

Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia (FREESIA-3)

James B. Bussel, Pamela Baker, Edwin Lam, Paige Meizlik, Hein Fennema, Rebecca Zaha, Hillary Van Valkenburgh, Kattayoun Kordy

 

View poster

Health Resource Utilization Among Patients with Warm Autoimmune Hemolytic Anemia in Sweden: A Retrospective Registry-Based Study

Christian Kjellander, Concetta Crivera, Ann Leon, Qian Cai, Tina Jacob, Erwei Zeng, Christina Jones, Amy Leval, Marie Fitzgibbon, Wim Noel, Cathye Shu, Gunnar Larfors

 

View poster

Sentiment Analysis Applied to Digital Conversations Among Warm Autoimmune Hemolytic Anemia (wAIHA) Patients Receiving Rituximab and/or Blood Transfusion

Caroline Piatek, Louis Jackson, Caroline Brethenoux, Alyssa DeLuca, Zia Choudhry, Jacqueline Pesa, Alex Lorenzo, Patrick Furey, Laura Gonzalez Quijano, Rosario Alvarez, Julija Paskevicius, Nora Sandorfi

 

View poster